title: Updates in vaccination: recommendations for adult inflammatory bowel disease patients.
abstract: Treatment regimens for inflammatory bowel disease (IBD) incorporate the use of a variety of immunosuppressive agents that increase the risk of infections. Prevention of many of these infections can be achieved by the timely and judicious use of vaccinations. IBD patients tend to be under-immunized. Some of the contributing factors are lack of awareness regarding the significance of vaccinating IBD patients, misperception about safety of vaccinations in immunocompromised patients, ambiguity about the perceived role of the gastroenterologist in contrast to the primary care physician and unavailability of vaccination guidelines focused on IBD population. In general, immunocompetent IBD patients can be vaccinated using standard vaccination recommendations. However there are special considerations for IBD patients receiving immunosuppressive therapy, IBD travelers and pregnant women with IBD. This review discusses current vaccination recommendations with updates for adult IBD patients. Centers for Disease Control and Prevention 2013 vaccination guidelines with 2014 updates and the Advisory Committee on Immunization Practices recommendations have been highlighted as a primary source of recommendations.
authors: Khadija Chaudrey, Tauseef Ali, Department of Medicine, Section of Gastroenterology, Oklahoma University Health Sciences Center, Oklahoma, OK 73104, United States.
authors: Khadija
authors: K
authors: Chaudrey
authors: Khadija Chaudrey, Tauseef Ali, Department of Medicine, Section of Gastroenterology, Oklahoma University Health Sciences Center, Oklahoma, OK 73104, United States.
authors: Michelle
authors: M
authors: Salvaggio
authors: Khadija Chaudrey, Tauseef Ali, Department of Medicine, Section of Gastroenterology, Oklahoma University Health Sciences Center, Oklahoma, OK 73104, United States.
authors: Aftab
authors: A
authors: Ahmed
authors: Khadija Chaudrey, Tauseef Ali, Department of Medicine, Section of Gastroenterology, Oklahoma University Health Sciences Center, Oklahoma, OK 73104, United States.
authors: Sultan
authors: S
authors: Mahmood
authors: Khadija Chaudrey, Tauseef Ali, Department of Medicine, Section of Gastroenterology, Oklahoma University Health Sciences Center, Oklahoma, OK 73104, United States.
authors: Tauseef
authors: T
authors: Ali
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D007114:Immunization / Q000009:adverse effects / Q000379:methods* / Q000592:standards; D007115:Immunization Schedule; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D015212:Inflammatory Bowel Diseases / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009894:Opportunistic Infections / Q000175:diagnosis / Q000276:immunology / Q000517:prevention & control* / Q000635:transmission; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000276:immunology / Q000517:prevention & control; D012307:Risk Factors; D014195:Travel; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents
keywords: Centers for Disease Control and Prevention; Immunocompromised; Influenza; Inﬂammatory bowel disease; Pneumococcal; Vaccination